Zydus received final approval for Ezetimibe Tablets
From USFDA
Zydus Cadila has received final approval from the USFDA to market Ezetimibe Tablets USP, 10 mg. Ezetimibe is a drug used to reduce high cholesterol levels. It will be produced at the group's formulations manufacturing facility at Moraiya, Ahmedabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content